Lunesta 3 mg/1
ESZOPICLONE · TABLET, COATED · Waylis Therapeutics LLC
No Recall History
Plain English
Lunesta is a tablet, coated containing eszopiclone at 3 mg/1, taken oral. Manufactured by Waylis Therapeutics LLC.
Key Facts
- Brand Name
- Lunesta
- Generic Name
- ESZOPICLONE
- NDC Code (Product)
80725-012- Manufacturer
- Waylis Therapeutics LLC
- Strength
- 3 mg/1
- Dosage Form
- TABLET, COATED
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA021476
- Marketing Start
- 08/15/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Lunesta used for?
Lunesta contains ESZOPICLONE. It is a tablet, coated taken oral. Consult your doctor for specific uses.
Is Lunesta a controlled substance?
Yes, Lunesta is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for Lunesta?
The generic name for Lunesta is ESZOPICLONE. There are 12 other brand versions of ESZOPICLONE.
What is the NDC code for Lunesta 3 mg/1?
The NDC (National Drug Code) for Lunesta 3 mg/1 is 80725-012, listed by Waylis Therapeutics LLC.